NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, November 7, 2024. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at http://www.siga.com in the Invest ...

The latest trading session saw Siga Technologies Inc. (SIGA) ending at $7.08, denoting a -0.42% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a loss of 0.33% for the day. At the same time, the Dow lost 0.22%, and the tech-heavy Nasdaq lost 0.56%.The company's shares have seen an increase of 2.01% over the last month, surpassing the Medical sector's loss of 4.31% and the S&P 500's gain of 1.83%.Analysts and investors alike will be keeping a close eye on the perfo ...

NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, today announced that it entered into an agreement with Vanderbilt University to obtain a license to a portfolio of preclinical fully human monoclonal antibodies (mAbs) which could be used as potential treatments for a broad range of orthopoxviruses, including smallpox and mpox. Under the agreement, SIGA has exercised its option to license the ...

Siga Technologies Inc. (SIGA) closed the most recent trading day at $6.80, moving +0.89% from the previous trading session. This move outpaced the S&P 500's daily gain of 0.47%. Meanwhile, the Dow gained 0.79%, and the Nasdaq, a tech-heavy index, added 0.28%. The company's shares have seen a decrease of 14.47% over the last month, not keeping up with the Medical sector's loss of 4.27% and the S&P 500's gain of 3.48%. The upcoming earnings release of Siga Technologies Inc. will be of great interest to invest ...

NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, today announced that it entered into an agreement to supply TPOXX (tecovirimat) in Morocco. The contract was executed in response to a request from the Ministry of Health in Morocco to make the therapy available in the country and help prepare and protect its citizens against any potential mpox outbreak. Tecovirimat is approved in the U.S., C ...

NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against SIGA Technologies, Inc. ("SIGA" or the "Company") (NASDAQ: SIGA) on behalf of SIGA stockholders. Our investigation concerns whether SIGA has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On September 23, 2024, after market hours, SIGA disclosed that its Chief ...

Siga Technologies Inc. (SIGA) ended the recent trading session at $6.99, demonstrating a +0.36% swing from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.9%. Meanwhile, the Dow gained 0.81%, and the Nasdaq, a tech-heavy index, added 1.22%. The company's stock has dropped by 12.67% in the past month, falling short of the Medical sector's loss of 4.05% and the S&P 500's gain of 3.15%. Investors will be eagerly watching for the performance of Siga Technolog ...

SAN FRANCISCO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Biopharmaceutical company SIGA Technologies is under intense scrutiny over its prior disclosures regarding the potential expansion of its lead product, TPOXX®, to treat Mpox. Hagens Berman encourages SIGA Technologies, Inc. (NASDAQ: SIGA) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may assist the investigation to contact its attorneys. Visit: www.hbsslaw.com/investor-fraud/siga Conta ...

NEW YORK, Sept. 26, 2024 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating potential securities claims on behalf of purchasers of SIGA Technologies, Inc.(NASDAQ: SIGA) ("SIGA" or the "Company") SIGA Technologies, Inc. operates as a commercial-stage pharmaceutical company. The Company offers oral formulation of an antiviral drug for the treatment of human smallpox disease caused by vario ...

Siga Technologies Inc. (SIGA) ended the recent trading session at $8.43, demonstrating no swing from the preceding day's closing price. This change lagged the S&P 500's daily gain of 0.28%. Meanwhile, the Dow gained 0.15%, and the Nasdaq, a tech-heavy index, added 0.15%. Prior to today's trading, shares of the company had lost 11.17% over the past month. This has lagged the Medical sector's gain of 0.38% and the S&P 500's gain of 2% in that time. The investment community will be paying close attention to th ...